← Open Payments lookup

PATRICIA KRAYCINOVICH: Open Payments

NPI 1497269625 · ENGLEWOOD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,103 in 65 payments from 16 companies in 2025. Trend: 2023 $849 · 2024 $1,019 · 2025 $1,103

Food & beverage: $1,103
CompanyPaymentsAmount
Madrigal Pharmaceuticals5$177
ABBVIE INC.11$174
Takeda Pharmaceuticals U.S.A., Inc.11$164
PFIZER INC.13$146
Janssen Biotech, Inc.7$113
Aimmune Therapeutics, Inc.3$58
QOL Medical, LLC2$47
Ardelyx, Inc.2$38
Ipsen Biopharmaceuticals, Inc2$35
VIVUS LLC2$32

Products named: REZDIFFRA, VELSIPITY, ENTYVIO, TREMFYA, RINVOQ, ZENPEP, SKYRIZI, Sucraid.

Industry payments across NJ — which companies pay providers there.